Wealthfront Advisers LLC Abb Vie Inc. Transaction History
Wealthfront Advisers LLC
- $29.7 Billion
- Q2 2024
A detailed history of Wealthfront Advisers LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 134,109 shares of ABBV stock, worth $26.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
134,109
Previous 137,853
2.72%
Holding current value
$26.9 Million
Previous $25.1 Million
8.37%
% of portfolio
0.08%
Previous 0.09%
Shares
23 transactions
Others Institutions Holding ABBV
# of Institutions
3,785Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$10.4 Billion0.84% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...